Human Smad3 and Smad4 are sequence-specific transcription activators

Molecular Cell

Volumn 1, Issue 4, 1998, Pages 611-617

  Zawel, Leigh ^a   Le Dai, Jia ^b   Buckhaults, Phillip ^a   Zhou, Shibin ^a   Kinzler, Kenneth W ^a   Vogelstein, Bert ^a   Kern, Scott E ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; SMAD3 PROTEIN; SMAD3 PROTEIN, HUMAN; SMAD4 PROTEIN; SMAD4 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CHEMISTRY; CONSENSUS SEQUENCE; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION; TRANSACTIVATION; TUMOR SUPPRESSOR GENE;

CONSENSUS SEQUENCE; DNA-BINDING PROTEINS; GENES, TUMOR SUPPRESSOR; HUMANS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032014216     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(00)80061-1     Document Type: Article

References (39)

1. Baker, J.C., and Harland, R.M. (1996). A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. Genes Dev. 10, 1880-1889.
2. Carcamo, J., Weis, F.M., Ventura, F., Wieser, R., Wrana, J.L., Attisano, L., and Massague, J. (1994). Type I receptors specify growth-inhibitory and transcriptional responses to TGF-β and activin. Mol. Cell. Biol. 14, 3810-3821.
3. Carcamo, J., Zentella, A., and Massague, J. (1995). Disruption of TGF-β signaling by a mutation that prevents transphosphorylation within the receptor complex. Mol. Cell. Biol. 15, 1573-1581.
4. Chen, X., Rubock, M.J., and Whitman, M. (1996). A transcriptional partner for MAD proteins in TGF-β signaling. Nature 383, 691-696.
5. Chen, X., Weisberg, E., Fridmacher, V., Watanabe, M., Naco, G., and Whitman, M. (1997). Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 389, 85-89.
6. Eppert, K., Scherer, S.W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L.-C., Bapat, B., Gallinger, S., Andrulis, I.L., et al. (1996). MADR2 maps to 18q21 and encodes a TGF-β-regulated MAD-related protein that is mutated in colorectal carcinoma. Cell 86, 543-552.
7. Hahn, S.A., Hoque, A.T., Moskaluk, C.A., da Costa, L.T., Schutte, M., Rozenblum, E., Seymour, A.B., Weinstein, C.L., Yeo, C.J., Hruban, R.H., and Kern, S.E. (1996). Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res. 56, 490-494.
8. Hahn, S.A., Schutte, M., Hoque, A.T.M.S., Moskaluk, C.A., Dacosta, L.T., Rozenblum, E., Weinstein, C.L., Fischer, A., Yeo, C.J., Hruban, R.H., and Kern, S.E. (1996). Dpc4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271, 350-353.
9. Heldin, C.H., Miyazono, K., and ten Dijke, P. (1997). TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.
10. Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K.W., and Vogelstein, B. (1997). 14-3-3σ is a p53-regulated inhibitor of G2/M progression. Molecular Cell 1, 3-11.
11. Hoodless, P. (1996). MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85, 489-500.
12. Hoodless, P.A., and Wrana, J.L. (1998). Mechanism and function of signaling by the TGF-β superfamily. Curr. Top. Microbiol. Immunol. 228, 235-272.
13. Hoque, A.T., Hahn, S.A., Schutte, M., and Kern, S.E. (1997). DPC4 gene mutation in colitis associated neoplasia. Gut 40, 120-122.
14. Kim, J., Johnson, K., Chen, H.J., Carroll, S., and Laughon, A. (1997). Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic. Nature 388, 304-308.
15. Kinzler, K.W., and Vogelstein, B. (1989). Whole genome PCR: application to the identification of sequences bound by gene regulatory proteins. Nucleic Acids Res. 17, 3645-3653.
16. Kretzschmar, M., Liu, F., Hata, A., Doody, J., and Massague, J. (1997). The TGF-β family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev. 11, 984-995.
17. Lagna, G., Hata, A., Hemmati-Brivanlou, A., and Massague, J. (1996). Partnership between DPC4 and SMAD proteins in TGF-β signaling pathways. Nature 383, 832-836.
18. Landesman, Y., Pagano, M., Draetta, G., Rotter, V., Fusenig, N.E., and Kimchi, A. (1992). Modifications of cell cycle controlling nuclear proteins by TGF-β in the HaCaT keratinocyte cell line. Oncogene 7, 1661-1665.
19. Liu, F., Hata, A., Baker, J.C., Doody, J., Carcamo, J., Harland, R.M., Massague, J. (1996). A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381, 620-623.
20. Liu, F., Pouponnot, C., and Massague, J. (1997a). Dual role of the Smad4/DPC4 tumor suppressor in TGF-β-inducible transcriptional complexes. Genes Dev. 11, 3157-3167.
21. Liu, X., Sun, Y., Constantinescu, S.N., Karam, E., Weinberg, R.A., and Lodish, H.F. (1997b). TGF-β-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc. Natl. Acad. Sci. USA 94, 10669-10674.
22. Macias-Silva, M., Abdollah, S., Hoodless, P.A., Pirone, R., Attisano, L., and Wrana, J.L. (1996). MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87, 1215-1224.
23. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R.S., Zborowska, E., Kinzler, K.W., Vogelstein, B., et al. (1995). Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268, 1336-1338.
24. Nakao, A., Imamura, T., Souchelnytskyi, S., Kawabata, M., Ishisaki, A., Oeda, E., Tamaki, K., Hanai, J., Heldin, C.H., Miyazono, K., and ten Dijke, P. (1997). TGF-β receptor-mediated signaling through Smad2, Smad3 and Smad4. EMBO J. 16, 5353-5362.
25. Nakao, A., Roijer, E., Imamura, T., Souchelnytskyi, S., Stenman, G., Heldin, C.H., and ten Dijke, P. (1997). Identification of Smad2, a human Mad-related protein in the TGF-β signaling pathway. J. Biol. Chem. 272, 2896-2900.
26. Nakshatri, H., and Bhat-Nakshatri, P. (1997). Differential effect of Nonidet P40 on DNA binding of transcription factors. Anal. Biochem. 249, 103-104.
27. Oliphant, A.R., Brandl, C.J., and Struhl, K. (1989). Defining the sequence specificity of DNA-binding proteins by selecting binding sites from random-sequence oligonucleotides: analysis of yeast GCN4 protein. Mol. Cell. Biol. 9, 2944-2949.
28. Parsons, R., Myeroff, L.L., Liu, B., Willson, J.K., Markowitz, S.D., Kinzler, K.W., and Vogelstein, B. (1995). Microsatellite instability and mutations of the TGF-β type II receptor gene in colorectal cancer. Cancer Res. 55, 5548-5550.
29. Riggins, G.J., Kinzler, K.W., Vogelstein, B., and Thiagalingam, S. (1996). Mad-related genes in the human. Nat. Genet. 13, 347-349.
30. Savage, C., Das, P., Finelli, A.L., Townsend, S.R., Sun, C.Y., Baird, S.E., and Padgett, R.W. (1996). Caenorhabditis elegans genes Sma-2, Sma-3, and Sma-4 define a conserved family of TGF-β pathway components. Proc. Natl. Acad. Sci. USA 93, 790-794.
31. Sekelsky, J.J., Newfeld, S.J., Raftery, L.A., Chartoff, E.H., and Gelbart, W.M. (1995). Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics 139, 1347-1358.
32. Shi, Y., Hata, A., Lo, R.S., Massague, J., and Pavletich, N.P. (1997). A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature 388, 87-93.
33. Thiagalingam, S. (1996). Evaluation of chromosome 18q in colorectal cancers. Nat. Genet. 13, 343-346.
34. Wang, J., Sun, L., Myeroff, L., Wang, X., Gentry, L.E., Yang, J., Liang, J., Zborowska, E., Markowitz, S., Willson, J.K., et al. (1995). Demonstration that mutation of the type II TGF-β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J. Biol. Chem. 270, 22044-22049.
35. Wrana, J.L., Attisano, L., Carcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X.F., and Massague, J. (1992). TGF-β signals through a heteromeric protein kinase receptor complex. Cell 71, 1003-1014.
36. Wu, R.Y., Zhang, Y., Feng, X.H., and Derynck, R. (1997). Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4. Mol. Cell. Biol. 17, 2521-2528.
37. Yingling, J.M., Datto, M.B., Wong, C., Frederick, J.P., Liberati, N.T., and Wang, X.F. (1997). Tumor suppressor Smad4 is a TGF-β-inducible DNA binding protein. Mol. Cell. Biol. 17, 7019-7028.
38. Zhang, Y., Feng, X., Wu, R., and Derynck, R. (1996). Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature 383, 168-172.
39. Zhou, S., Buckhaults, P., Zawel, L., Bunz, F., Riggins, G., Dai, J.L., Kern, S.E., Kinzler, K.W., and Vogelstein, B. (1998). Targeted deletion of Smad4 shows it is required for TGF-β and activin signaling in colorectal cancer cells. Proc. Natl. Acad. Sci. USA 95, 2412-2416.